Tuesday, June 14, 2011

Biomarkers to experience explosive growth among global emerging pharmaceutical technologies

The total global emerging technologies market is comprised of a variety of fast growing and independent segments like therapeutic vaccines; infectious disease treatments; biomarkers; next-generation cardiovascular therapies; leading ophthalmic treatments; CNS: next-generation mechanisms of action; and cancer trends: evolving therapies. Out of these, biomarkers will experience explosive growth, increasing from a current $13.5 billion to $33.3 billion in 2015, a 19.8% CAGR for the forecast period.

Learn about the emerging pharmaceutical technologies on a global basis. Get information on products within disease sub segments, overall industry trends and relevant company profiles...

Use this report to:
  • Quantify and qualify emerging markets for therapeutic drug products by product, product category, and by company 
  • Develop strategies for accessing emerging markets by specific disease segments and geography in order to allocate resources and make effective decisions  
  • Evaluate leading and emerging competitors, including companies with novel products in development, how their specific product strategies are employed, and how these new products and technologies are influencing the current standard of care  
  • Identify overall market trends, product opportunities, emerging geographies, M&A opportunities and guiding insights for sales growth.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.


No comments:

Post a Comment

Bookmark and Share